A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of Linaclotide Administered Orally to Children, Ages 6 to 17 Years, With Functional Constipation (FC) - Trial 2019-001500-38
Access comprehensive clinical trial information for 2019-001500-38 through Pure Global AI's free database. This phase not specified trial is sponsored by AbbVie Deutschland GmbH & Co. KG and is currently Ongoing. The study focuses on Functional Constipation.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2019-001500-38
Ongoing
Trial Details
EU Clinical Trials Register • 2019-001500-38
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of Linaclotide Administered Orally to Children, Ages 6 to 17 Years, With Functional Constipation (FC)
Study Focus
Sponsor & Location
AbbVie Deutschland GmbH & Co. KG
AbbVie Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
1.Medical Conditions
ICD-10 Classifications
Constipation
Other functional intestinal disorders
Functional intestinal disorder, unspecified
Other specified functional intestinal disorders
Other laxatives
Data Source
EU Clinical Trials Register
2019-001500-38
Non-Device Trial